Published Date: February, 2018
A recent report published by Infinium Global Research on women's health market provides in depth analysis of segments and sub-segments in global as well as regional women's health market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional women's health market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global women's health market. According to report the global women's health market was worth USD 43.52 billion in 2016 and it is projected to reach USD 57.89 billion in 2023 growing at a CAGR of 5.72% over the forecast period of 2018-2024.
A woman has unique health issues such as pregnancy, menopause, and other diseases. The innovations in prescription drugs for women health are used to treat a number of diseases and conditions in a variety of therapeutic areas. According to eHealthMe, about 52.3% of women in age of 50 to 59 suffer from menopause uses antidepressant therapy. Growing female elderly population, unhealthy lifestyle, satisfactory government strategies & initiatives by private organizations are some of the drivers that boost the market. Research and development for innovation of new medicines for women is likely to surge this market. Additionally increasing awareness among society about the availability of treatment for women’s health related diseases propel the growth of this market.Moreover, improving healthcare organization in emerging markets and rising number of government approvals for immunoassay techniques provide substantial growth opportunities for key players in the women health market.
The report on global women's health market covers segments such as, treatment type, diseases indication and distribution channel. On the basis of treatment type the global women's health market is categorized into hormonal and non-hormonal. Combination therapy, thyroid replacement therapy, estrogen therapy, progestin therapy, parathyroid hormone therapy, and others is sub segment of hormonal treatment type. Cancer targeted therapy drugs, antibiotics, bisphosphonates, and others are included in non-hormonal treatment segment. On the basis of diseases indication the global women's health market is categorized into hypothyroidism, osteoporosis, uterine fibroid, cancer, post-menopausal syndrome, contraceptive, urinary tract infection and others. On the basis of distribution channel the global women's health market is categorized into online pharmacy, hospital pharmacy and retail pharmacy.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2016-2024.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global women's health market such as, Novartis AG, Merck & Co., Inc., Amgen Inc, Eli Lilly and Company, Lupin Pharmaceuticals, Inc., Novo Nordisk A/S, AstraZeneca, Pfizer, Inc., Sanofi and Other. This industry feature for merger and acquision as an explanations strategy for instance Ahmedabad-based Torrent Pharma has completed the acquisition of women healthcare brands Regestrone and Pregachieve for India from Swiss pharma major Novartis AG.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global women's health market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of women's health market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the women's health market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the women's health market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Womens Health Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Womens Health Market
4. Global Womens Health Market by Treatment Type
4.1.1. Combination Therapy
4.1.2. Parathyroid Hormone Therapy
4.1.3. Thyroid Replacement Therapy Estrogen Therapy
4.1.4. Progestin Therapy
4.2.1. Targeted Therapy Drugs
5. Global Womens Health Market by Diseases Indication
5.3. Uterine Fibroid
5.5. Post-Menopausal Syndrome
5.7. Urinary Tract Infection
6. Global Womens Health Market by Distribution Channel
6.1. Online Pharmacy
6.2. Hospital Pharmacy
6.3. Retail Pharmacy
7. Global Womens Health Market by Region 2018-2024
7.1. North America
7.1.1. North America Womens Health Market by Treatment Type
7.1.2. North America Womens Health Market by Diseases Indication
7.1.3. North America Womens Health Market by Distribution Channel
7.1.4. North America Womens Health Market by Country
7.2.1. Europe Womens Health Market by Treatment Type
7.2.2. Europe Womens Health Market by Diseases Indication
7.2.3. Europe Womens Health Market by Distribution Channel
7.2.4. Europe Womens Health Market by Country
7.3.1. Asia-Pacific Womens Health Market by Treatment Type
7.3.2. Asia-Pacific Womens Health Market by Diseases Indication
7.3.3. Asia-Pacific Womens Health Market by Distribution Channel
7.3.4. Asia-Pacific Womens Health Market by Country
7.4.1. RoW Womens Health Market by Treatment Type
7.4.2. RoW Womens Health Market by Diseases Indication
7.4.3. RoW Womens Health Market by Distribution Channel
7.4.4. RoW Womens Health Market by Sub-region
8. Company Covered
8.1. Novartis AG
8.2. Merck & Co., Inc.
8.3. Amgen Inc
8.4. Eli Lilly and Company
8.5. Lupin Pharmaceuticals, Inc.
8.6. Novo Nordisk A/S
8.8. Pfizer, Inc.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter